Skip to main content

Advertisement

Table 2 Anthropometric measures at baseline (ITT: number (N) = 64) in groups to be treated with polyglucosamine and orlistat

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable Total Group polyglucosamine Group orlistat pa/b
N 64 32 32
Gender (male/female) 28/36 16/16 12/20 P = 0.313a
Age (years) 50.0 ± 9.17 50.0 ± 9.10 50.1 ± 9.38 P = 0.989b
Weight (kg) 99.4 ± 12.33 100.6 ± 13.22 98.2 ± 11.47 P = 0.446b
Height (m) 169.3 ± 8.09 170.3 ± 7.60 168.4 ± 8.58 P = 0.358b
BMI (kg/m2) 34.7 ± 4.21 34.6 ± 3.70 34.8 ± 4.73 P = 0.896b
WC (cm) 111.2 ± 10.66 112.4 ± 10.95 110.0 ± 10.38 P = 0.358b
  1. aChi square test; bt test